Prestige BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 13, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2020
Market Capitalization	188,942	103,966	113,582	137,620	396,635	-	Upgrade
Market Cap Growth	55.01%	-8.47%	-17.47%	-65.30%	-	-	Upgrade
Enterprise Value	222,457	44,042	-6,736	-150,494	-63,944	-	Upgrade
Last Close Price	15720.00	8650.00	9450.00	11450.00	33000.00	-	Upgrade
PE Ratio	43.45	-	6.47	-	-	-	Upgrade
Forward PE	-	12.01	12.01	12.01	-	-	Upgrade
PS Ratio	21.81	150.88	701.81	-	-	-	Upgrade
PB Ratio	0.35	0.20	0.21	0.32	0.69	-	Upgrade
P/TBV Ratio	0.47	0.26	0.28	0.32	0.69	-	Upgrade
EV/Sales Ratio	25.68	63.92	-	-	-	-	Upgrade
Debt / Equity Ratio	0.27	0.20	0.21	0.01	0.01	0.02	Upgrade
Debt / EBITDA Ratio	-	-	9.11	-	-	-	Upgrade
Asset Turnover	0.01	0.00	0	-	-	-	Upgrade
Inventory Turnover	0.08	0.10	0.01	-	-	-	Upgrade
Quick Ratio	1.23	1.57	2.24	7.26	32.70	5.71	Upgrade
Current Ratio	1.38	1.72	2.31	7.46	32.74	5.88	Upgrade
Return on Equity (ROE)	0.04%	-10.38%	-0.59%	-42.08%	-2.07%	-15.29%	Upgrade
Return on Assets (ROA)	-5.17%	-5.35%	0.10%	-13.89%	-3.01%	-6.12%	Upgrade
Return on Capital (ROIC)	-5.90%	-6.07%	0.12%	-15.08%	-3.18%	-7.41%	Upgrade
Return on Capital Employed (ROCE)	-	-	0.20%	-	-	-	Upgrade
Earnings Yield	11.53%	-31.66%	15.47%	-153.65%	-1.86%	-	Upgrade
FCF Yield	-52.38%	-65.49%	-95.65%	-74.36%	-4.13%	-	Upgrade
Buyback Yield / Dilution	-0.07%	-	-	-16.46%	-20.98%	-7.27%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.